STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, has announced its participation in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference. The event is scheduled for September 12, 2024, at the Yale Club in Midtown Manhattan, New York City.
Dr. Dolev Rafaeli, President and CEO of STRATA, will represent the company at the conference. STRATA will be hosting one-on-one investor meetings throughout the event, providing an opportunity for investors to engage directly with the company's leadership. Interested parties can schedule meetings through their Lake Street representatives.
This participation underscores STRATA's commitment to investor relations and its ongoing efforts to showcase its innovative products in the dermatologic field to potential investors and industry professionals.
STRATA Skin Sciences (NASDAQ: SSKN), un'azienda tecnologica medica focalizzata sui trattamenti dermatologici, ha annunciato la sua partecipazione alla 8ª Conferenza Annuale delle Migliori Idee di Lake Street Capital Markets. L'evento è programmato per il 12 settembre 2024, presso il Yale Club a Midtown Manhattan, New York City.
Il Dr. Dolev Rafaeli, Presidente e CEO di STRATA, rappresenterà l'azienda durante la conferenza. STRATA ospiterà incontri individuali con gli investitori durante l'evento, offrendo un'opportunità agli investitori di interagire direttamente con la leadership dell'azienda. Le parti interessate possono programmare incontri tramite i loro rappresentanti di Lake Street.
Questa partecipazione sottolinea l'impegno di STRATA nei rapporti con gli investitori e i suoi continui sforzi per mettere in mostra i suoi prodotti innovativi nel campo dermatologico a potenziali investitori e professionisti del settore.
STRATA Skin Sciences (NASDAQ: SSKN), una empresa de tecnología médica enfocada en tratamientos dermatológicos, ha anunciado su participación en la 8ª Conferencia Anual de Mejores Ideas de Lake Street Capital Markets. El evento está programado para el 12 de septiembre de 2024, en el Yale Club en Midtown Manhattan, Nueva York.
El Dr. Dolev Rafaeli, Presidente y CEO de STRATA, representará a la empresa en la conferencia. STRATA llevará a cabo reuniones individuales con inversores durante todo el evento, ofreciendo la oportunidad a los inversores de interactuar directamente con el liderazgo de la empresa. Las partes interesadas pueden programar reuniones a través de sus representantes de Lake Street.
Esta participación subraya el compromiso de STRATA con las relaciones con los inversores y sus esfuerzos continuos por presentar sus productos innovadores en el campo dermatológico a posibles inversores y profesionales de la industria.
STRATA Skin Sciences (NASDAQ: SSKN), 피부 치료에 집중하는 의료 기술 회사가 Lake Street Capital Markets 제8회 연례 최고의 아이디어 성장 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 12일에 뉴욕 맨해튼 미드타운에 위치한 Yale Club에서 개최될 예정입니다.
STRATA의 사장 겸 CEO인 Dolev Rafaeli 박사가 컨퍼런스에서 회사를 대표할 것입니다. STRATA는 행사 기간 동안 개별 투자자 미팅을 주최하여 투자자들이 회사의 리더십과 직접 소통할 수 있는 기회를 제공합니다. 관심 있는 분들은 Lake Street의 대표를 통해 미팅을 예약할 수 있습니다.
이번 참가를 통해 STRATA는 투자자 관계에 대한 헌신과 피부과 분야에서 혁신적인 제품을 잠재적 투자자 및 업계 전문가들에게 선보이기 위한 지속적인 노력을 강조합니다.
STRATA Skin Sciences (NASDAQ: SSKN), une entreprise de technologie médicale axée sur les traitements dermatologiques, a annoncé sa participation à la 8ème Conférence Annuelle des Meilleures Idées de Lake Street Capital Markets. L'événement est programmé pour le 12 septembre 2024, au Yale Club à Midtown Manhattan, New York.
Le Dr Dolev Rafaeli, Président et CEO de STRATA, représentera l'entreprise lors de la conférence. STRATA organisera des réunions individuelles avec des investisseurs tout au long de l'événement, offrant aux investisseurs l'opportunité d'interagir directement avec la direction de l'entreprise. Les parties intéressées peuvent planifier des réunions par l'intermédiaire de leurs représentants de Lake Street.
Cette participation souligne l'engagement de STRATA envers les relations avec les investisseurs et ses efforts continus pour présenter ses produits innovants dans le domaine dermatologique à des investisseurs potentiels et des professionnels du secteur.
STRATA Skin Sciences (NASDAQ: SSKN), ein Medizintechnikunternehmen, das sich auf dermatologische Behandlungen konzentriert, hat seine Teilnahme an der 8. jährlichen Best Ideas Growth Conference von Lake Street Capital Markets angekündigt. Die Veranstaltung ist für den 12. September 2024 im Yale Club in Midtown Manhattan, New York City, geplant.
Dr. Dolev Rafaeli, Präsident und CEO von STRATA, wird das Unternehmen bei der Konferenz vertreten. STRATA wird während der gesamten Veranstaltung eins-zu-eins-Investorenmeetings abhalten, was den Investoren die Möglichkeit gibt, direkt mit der Unternehmensführung in Kontakt zu treten. Interessierte Parteien können Meetings über ihre Vertreter von Lake Street vereinbaren.
Diese Teilnahme unterstreicht STRATAs Engagement für die Beziehungen zu Investoren und deren anhaltende Bemühungen, ihre innovativen Produkte im dermatologischen Bereich potenziellen Investoren und Branchenfachleuten zu präsentieren.
- None.
- None.
HORSHAM, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on Thursday, September 12, 2024, at the Yale Club in Midtown Manhattan, New York City.
The Company will host one-on-one investor meetings throughout the conference.
For more information or to schedule a meeting, please contact your Lake Street representative at conference@lakestreetcm.com.
About STRATA Skin Sciences
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System.
STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure (versus an equipment purchase), installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.
Safe Harbor
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to consumer marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from fiscal, political factors, international conflicts, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.
Investor Contact:
CORE IR
516-222-2560
IR@strataskin.com
FAQ
When is STRATA Skin Sciences (SSKN) participating in the Lake Street Capital Markets conference?
Where is the Lake Street Capital Markets conference being held for STRATA Skin Sciences (SSKN)?
Who will represent STRATA Skin Sciences (SSKN) at the Lake Street Capital Markets conference?
What type of meetings will STRATA Skin Sciences (SSKN) host at the conference?